日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Investigation of the Biological Properties of Non-small Cell Lung Cancer Using Three-dimensional Computed Tomography Images

利用三维计算机断层扫描图像研究非小细胞肺癌的生物学特性

期刊:
影响因子:
doi:10.21873/cdp.10458
Haro, Akira; Wakasu, Sho; Kozuma, Yuka; Tsukamoto, Shuichi; Hamatake, Motoharu
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Chest wall tuberculosis: precision surgery with indigo carmine in limited cases for safe and intuitive lesion excision

胸壁结核：在少数情况下，使用靛蓝胭脂红进行精准手术，以实现安全、直观的病灶切除

期刊:Interdisciplinary Cardiovascular and Thoracic Surgery
影响因子:1.3
doi:10.1093/icvts/ivae036
Abe, Sosei; Okabayashi, Kan; Tokuishi, Keita; Nakashima, Hiroyasu; Maekawa, Shin-Ichi; Hamatake, Daisuke; Sato, Toshihiko
发表日期：2024
文献求助 收藏

Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer?

根治性局部治疗对术后复发的EGFR突变型非小细胞肺癌有效吗？

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14911
Takenaka, Tomoyoshi; Yano, Tokujiro; Yamazaki, Koji; Okamoto, Tatsuro; Hamatake, Motoharu; Takamori, Shinkichi; Kohno, Mikihiro; Miura, Naoko; Shimokawa, Mototsugu; Yoshizumi, Tomoharu
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2023
文献求助 收藏

Mutation and apoptosis are well-coordinated for protecting against DNA damage-inducing toxicity in Drosophila

在果蝇中，突变和细胞凋亡协调一致，共同抵御DNA损伤引起的毒性。

期刊:Genes and Environment
影响因子:1.9
doi:10.1186/s41021-023-00267-4
Toyoshima-Sasatani, Megumi; Imura, Fumika; Hamatake, Yuko; Fukunaga, Akihiro; Negishi, Tomoe
Drosophila
凋亡
表观遗传
细胞生物学
毒理研究
发表日期：2023
文献求助 收藏

Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy

评估白蛋白-胆红素分级作为接受抗PD-1治疗的非小细胞肺癌患者预后因素的价值

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100348
Takada, K; Takamori, S; Shimokawa, M; Toyokawa, G; Shimamatsu, S; Hirai, F; Tagawa, T; Okamoto, T; Hamatake, M; Tsuchiya-Kawano, Y; Otsubo, K; Inoue, K; Yoneshima, Y; Tanaka, K; Okamoto, I; Nakanishi, Y; Mori, M
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2022
文献求助 收藏

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

一项采用倾向评分匹配分析的方法，探讨他汀类药物治疗对接受抗PD-1单药治疗的非小细胞肺癌患者预后的影响：一项多中心回顾性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09385-8
Takada, Kazuki; Shimokawa, Mototsugu; Takamori, Shinkichi; Shimamatsu, Shinichiro; Hirai, Fumihiko; Tagawa, Tetsuzo; Okamoto, Tatsuro; Hamatake, Motoharu; Tsuchiya-Kawano, Yuko; Otsubo, Kohei; Inoue, Koji; Yoneshima, Yasuto; Tanaka, Kentaro; Okamoto, Isamu; Nakanishi, Yoichi; Mori, Masaki
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2022
文献求助 收藏

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors

合并用药对接受免疫检查点抑制剂治疗的术后复发性非小细胞肺癌患者预后的临床影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0263247
Takada, Kazuki; Shimokawa, Mototsugu; Takamori, Shinkichi; Shimamatsu, Shinichiro; Hirai, Fumihiko; Ono, Yuki; Tagawa, Tetsuzo; Okamoto, Tatsuro; Hamatake, Motoharu; Okamoto, Isamu; Mori, Masaki
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study

对肠道微生物组进行时间序列分析以评估阿特珠单抗免疫疗法在非小细胞肺癌中的疗效：一项多中心前瞻性观察研究方案

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14640
Shoji, Fumihiro; Miura, Naoko; Tagawa, Tetsuzo; Tsukamoto, Shuichi; Okamoto, Tatsuro; Yamazaki, Koji; Hamatake, Motoharu; Takeo, Sadanori
肺癌
肿瘤
肿瘤免疫
微生物学
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study

非小细胞肺癌手术切除后复发患者的生存情况：一项多中心前瞻性队列研究

期刊:JTCVS Open
影响因子:1.9
doi:10.1016/j.xjon.2022.03.004
Takenaka, Tomoyoshi; Yano, Tokujiro; Yamazaki, Koji; Okamoto, Tatsuro; Hamatake, Motoharu; Shimokawa, Mototsugu; Mori, Masaki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study

在一项 Ib/IIa 期研究中，治疗性疫苗 BRII-179 可恢复慢性乙型肝炎患者的 HBV 特异性免疫反应。

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2021.100361
Ma, Haiyan; Lim, Tien Huey; Leerapun, Apinya; Weltman, Martin; Jia, Jidong; Lim, Young-Suk; Tangkijvanich, Pisit; Sukeepaisarnjaroen, Wattana; Ji, Yun; Le Bert, Nina; Li, Dong; Zhang, Yao; Hamatake, Robert; Tan, Nicole; Li, Chunming; Strasser, Simone I; Ding, Huiguo; Yoon, Jung-Hwan; Stace, Nigel H; Ahmed, Tanvir; Anderson, Dave E; Yan, Li; Bertoletti, Antonio; Zhu, Qing; Yuen, Man-Fung
肝炎
免疫/内分泌
发表日期：2021
文献求助 收藏